Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease

Cancer Treatment Reviews

Volumn 37, Issue 5, 2011, Pages 391-403

  van Leeuwen Segarceanu, Elena M ^a   Bos, Willem Jan W ^a   Dorresteijn, Lucille D A ^b   Rensing, Benno J W M ^a   der Heyden, Jan A S van ^a   Vogels, Oscar J M ^a   Biesma, Douwe H ^c  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Arrhythmias and conduction system disease; Cardiomyopathy; Cardiovascular complications; Carotid artery disease; Coronary artery disease; Hodgkin lymphoma; Pericardial disease; Radiotherapy; Screening; Valvular disease

Indexed keywords

AORTA VALVE DISEASE; ATHEROSCLEROSIS; CANCER RADIOTHERAPY; CANCER SURVIVOR; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CAROTID ARTERY DISEASE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; NONHUMAN; PERICARDIAL DISEASE; RADIATION DOSE; REVIEW; RISK FACTOR; SCREENING; SCREENING TEST; TREATMENT OUTCOME; VASCULAR DISEASE;

ADULT; AGED; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; DOSE-RESPONSE RELATIONSHIP, RADIATION; EARLY DIAGNOSIS; FEMALE; HODGKIN DISEASE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; PROGNOSIS; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RISK ASSESSMENT; SURVIVAL ANALYSIS; SURVIVORS;

EID: 79957529162     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2010.12.004     Document Type: Review

References (88)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96.
2. Heidenreich P.A., Schnittger I., Strauss H.W., et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol 2007, 25:43-49.
3. Kleikamp G., Schnepper U., Korfer R. Coronary artery and aortic valve disease as a long-term sequel of mediastinal and thoracic irradiation. Thorac Cardiovasc Surg 1997, 45:27-31.
4. Ng A., Constine L.S., Advani R., et al. Acr appropriateness criteria: follow-up of Hodgkin's lymphoma. Curr Probl Cancer 2010, 34:211-227.
5. National comprehensive cancer network: NCCN clinical practice guidelines in oncology: Hodgkin lymphoma. ; 2010. http://www.Nccn.Org/professionals/physician_gls/f_guidelines.Asp.
6. Children's oncology group: long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. ; 2008. http://www.Guidelines.Gov/summary/summary.Aspx?Ss=15&doc_id=10772&nbr=5600.
7. Mauch P.M., Kalish L.A., Marcus K.C., et al. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am 1995, 1:33-42.
8. Aleman B.M., van den Belt-Dusebout A.W., De Bruin M.L., et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 2007, 109:1878-1886.
9. Myrehaug S., Pintilie M., Tsang R., et al. Cardiac morbidity following modern treatment for Hodgkin lymphoma: supra-additive cardiotoxicity of doxorubicin and radiation therapy. Leuk Lymphoma 2008, 49:1486-1493.
10. Andersen R., Wethal T., Gunther A., et al. Relation of coronary artery calcium score to premature coronary artery disease in survivors >15years of Hodgkin's lymphoma. Am J Cardiol 2010, 105:149-152.
11. Boivin J.F., Hutchison G.B., Lubin J.H., Mauch P. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 1992, 69:1241-1247.
12. Hancock S.L., Tucker M.A., Hoppe R.T. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993, 270:1949-1955.
13. Swerdlow A.J., Higgins C.D., Smith P., et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst 2007, 99:206-214.
14. Lee C.K., Aeppli D., Nierengarten M.E. The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin's disease: University of Minnesota experience. Int J Radiat Oncol Biol Phys 2000, 48:169-179.
15. Reinders J.G., Heijmen B.J., Olofsen-van Acht M.J., van Putten W.L., Levendag P.C. Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up. Radiother Oncol 1999, 51:35-42.
16. Patel D.A., Kochanski J., Suen A.W., et al. Clinical manifestations of noncoronary atherosclerotic vascular disease after moderate dose irradiation. Cancer 2006, 106:718-725.
17. Hull M.C., Morris C.G., Pepine C.J., Mendenhall N.P. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 2003, 290:2831-2837.
18. Gustavsson A., Eskilsson J., Landberg T., et al. Late cardiac effects after mantle radiotherapy in patients with Hodgkin's disease. Ann Oncol 1990, 1:355-363.
19. Kupeli S., Hazirolan T., Varan A., et al. Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin's lymphoma. J Clin Oncol 2009.
20. Pohjola-Sintonen S., Totterman K.J., Salmo M., Siltanen P. Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin's disease. Cancer 1987, 60:31-37.
21. Kreuser E.D., Voller H., Behles C., et al. Evaluation of late cardiotoxicity with pulsed Doppler echocardiography in patients treated for Hodgkin's disease. Br J Haematol 1993, 84:615-622.
22. Gottdiener J.S., Katin M.J., Borer J.S., Bacharach S.L., Green M.V. Late cardiac effects of therapeutic mediastinal irradiation. Assessment by echocardiography and radionuclide angiography. N Engl J Med 1983, 308:569-572.
23. Pihkala J., Happonen J.M., Virtanen K., et al. Cardiopulmonary evaluation of exercise tolerance after chest irradiation and anticancer chemotherapy in children and adolescents. Pediatrics 1995, 95:722-726.
24. Watchie J., Coleman C.N., Raffin T.A., et al. Minimal long-term cardiopulmonary dysfunction following treatment for Hodgkin's disease. Int J Radiat Oncol Biol Phys 1987, 13:517-524.
25. King V., Constine L.S., Clark D., et al. Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease. Int J Radiat Oncol Biol Phys 1996, 36:881-889.
26. Glanzmann C., Kaufmann P., Jenni R., Hess O.M., Huguenin P. Cardiac risk after mediastinal irradiation for Hodgkin's disease. Radiother Oncol 1998, 46:51-62.
27. Reber D., Birnbaum D.E., Tollenaere P. Heart diseases following mediastinal irradiation: surgical management. Eur J Cardiothorac Surg 1995, 9:202-205.
28. Joensuu H. Acute myocardial infarction after heart irradiation in young patients with Hodgkin's disease. Chest 1989, 95:388-390.
29. Annest L.S., Anderson R.P., Li W., Hafermann M.D. Coronary artery disease following mediastinal radiation therapy. J Thorac Cardiovasc Surg 1983, 85:257-263.
30. Chronowski G.M., Wilder R.B., Tucker S.L., et al. Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy. Int J Radiat Oncol Biol Phys 2003, 55:36-43.
31. Rademaker J., Schoder H., Ariaratnam N.S., et al. Coronary artery disease after radiation therapy for Hodgkin's lymphoma: coronary ct angiography findings and calcium scores in nine asymptomatic patients. AJR Am J Roentgenol 2008, 191:32-37.
32. Piovaccari G., Ferretti R.M., Prati F., et al. Cardiac disease after chest irradiation for Hodgkin's disease: incidence in 108 patients with long follow-up. Int J Cardiol 1995, 49:39-43.
33. Murabito J.M., Evans J.C., Larson M.G., Levy D. Prognosis after the onset of coronary heart disease. An investigation of differences in outcome between the sexes according to initial coronary disease presentation. Circulation 1993, 88:2548-2555.
34. Apter S., Shemesh J., Raanani P., et al. Cardiovascular calcifications after radiation therapy for Hodgkin lymphoma: computed tomography detection and clinical correlation. Coron Artery Dis 2006, 17:145-151.
35. Zinzani P.L., Gherlinzoni F., Piovaccari G., et al. Cardiac injury as late toxicity of mediastinal radiation therapy for Hodgkin's disease patients. Haematologica 1996, 81:132-137.
36. Veeragandham R.S., Goldin M.D. Surgical management of radiation-induced heart disease. Ann Thorac Surg 1998, 65:1014-1019.
37. Orzan F., Brusca A., Conte M.R., Presbitero P., Figliomeni M.C. Severe coronary artery disease after radiation therapy of the chest and mediastinum: clinical presentation and treatment. Br Heart J 1993, 69:496-500.
38. McEniery P.T., Dorosti K., Schiavone W.A., Pedrick T.J., Sheldon W.C. Clinical and angiographic features of coronary artery disease after chest irradiation. Am J Cardiol 1987, 60:1020-1024.
39. Handa N., McGregor C.G., Danielson G.K., et al. Coronary artery bypass grafting in patients with previous mediastinal radiation therapy. J Thorac Cardiovasc Surg 1999, 117:1136-1142.
40. Hoving S., Heeneman S., Gijbels M.J., et al. Single-dose and fractionated irradiation promote initiation and progression of atherosclerosis and induce an inflammatory plaque phenotype in apoe(-/-) mice. Int J Radiat Oncol Biol Phys 2008, 71:848-857.
41. Carver J.R., Shapiro C.L., Ng A., et al. American society of clinical oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol 2007, 25:3991-4008.
42. Miltenyi Z., Keresztes K., Garai I., et al. Radiation-induced coronary artery disease in Hodgkin's disease. Cardiovasc Radiat Med 2004, 5:38-43.
43. Jurado J., Thompson P.D. Prevention of coronary artery disease in cancer patients. Pediatr Blood Cancer 2005, 44:620-624.
44. Chen A.B., Punglia R.S., Kuntz K.M., Mauch P.M., Ng A.K. Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors. J Clin Oncol 2009, 27:5383-5389.
45. Nathan D.M., Buse J.B., Davidson M.B., et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American diabetes association and the european association for the study of diabetes. Diabetes Care 2009, 32:193-203.
46. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
47. Grundy S.M., Cleeman J.I., Merz C.N., et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel iii guidelines. Circulation 2004, 110:227-239.
48. Hancock S.L., Donaldson S.S., Hoppe R.T. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 1993, 11:1208-1215.
49. Mulrooney D.A., Yeazel M.W., Kawashima T., et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the childhood cancer survivor study cohort. BMJ 2009, 339:b4606.
50. Preston D.L., Shimizu Y., Pierce D.A., Suyama A., Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 2003, 160:381-407.
51. Brosius F.C., Waller B.F., Roberts W.C. Radiation heart disease. Analysis of 16 young (aged 15-33years) necropsy patients who received over 3500rads to the heart. Am J Med 1981, 70:519-530.
52. Myrehaug S., Pintilie M., Yun L., et al. A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart disease. Blood 2010, 116:2237-2240.
53. http://seer.Cancer.Gov/statfacts/html/hodg.Html?Statfacts_page=hodg.Html&x=12&y=15.
54. Girinsky T., Cordova A., Rey A., et al. Thallium-201 scintigraphy is not predictive of late cardiac complications in patients with Hodgkin's disease treated with mediastinal radiation. Int J Radiat Oncol Biol Phys 2000, 48:1503-1506.
55. Constine L.S., Schwartz R.G., Savage D.E., King V., Muhs A. Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease. Int J Radiat Oncol Biol Phys 1997, 39:897-906.
56. Adams M.J., Lipsitz S.R., Colan S.D., et al. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 2004, 22:3139-3148.
57. Becker A., Leber A., Becker C., Knez A. Predictive value of coronary calcifications for future cardiac events in asymptomatic individuals. Am Heart J 2008, 155:154-160.
58. Schmermund A., Erbel R., Silber S. Age and gender distribution of coronary artery calcium measured by four-slice computed tomography in 2030 persons with no symptoms of coronary artery disease. Am J Cardiol 2002, 90:168-173.
59. Greenland P., Bonow R.O., Brundage B.H., et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the american college of cardiology foundation clinical expert consensus task force (ACCF/AHA writing committee to update the 2000 expert consensus document on electron beam computed tomography) developed in collaboration with the society of atherosclerosis imaging and prevention and the society of cardiovascular computed tomography. J Am Coll Cardiol 2007, 49:378-402.
60. Shaw L.J., Raggi P., Schisterman E., Berman D.S., Callister T.Q. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 2003, 228:826-833.
61. Heidenreich P.A., Hancock S.L., Lee B.K., Mariscal C.S., Schnittger I. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol 2003, 42:743-749.
62. Glanzmann C., Huguenin P., Lutolf U.M., et al. Cardiac lesions after mediastinal irradiation for Hodgkin's disease. Radiother Oncol 1994, 30:43-54.
63. Greenfield D.M., Wright J., Brown J.E., et al. High incidence of late effects found in Hodgkin's lymphoma survivors, following recall for breast cancer screening. Br J Cancer 2006, 94:469-472.
64. Lund M.B., Ihlen H., Voss B.M., et al. Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study. Heart 1996, 75:591-595.
65. Nishimura R.A., Carabello B.A., Faxon D.P., et al. ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines: endorsed by the society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, and society of thoracic surgeons. Circulation 2008, 118:887-896.
66. Bonow R.O., Carabello B.A., Kanu C., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): developed in collaboration with the society of cardiovascular anesthesiologists: endorsed by the society for cardiovascular angiography and interventions and the society of thoracic surgeons. Circulation 2006, 114:e84-231.
67. Chang A.S., Smedira N.G., Chang C.L., et al. Cardiac surgery after mediastinal radiation: extent of exposure influences outcome. J Thorac Cardiovasc Surg 2007, 133:404-413.
68. Handa N., McGregor C.G., Danielson G.K., et al. Valvular heart operation in patients with previous mediastinal radiation therapy. Ann Thorac Surg 2001, 71:1880-1884.
69. Wethal T., Lund M.B., Edvardsen T., et al. Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study. Br J Cancer 2009, 101:575-581.
70. Lund M.B., Kongerud J., Boe J., et al. Cardiopulmonary sequelae after treatment for Hodgkin's disease: increased risk in females?. Ann Oncol 1996, 7:257-264.
71. Carlson R.G., Mayfield W.R., Normann S., Alexander J.A. Radiation-associated valvular disease. Chest 1991, 99:538-545.
72. Applefeld M.M., Wiernik P.H. Cardiac disease after radiation therapy for Hodgkin's disease: analysis of 48 patients. Am J Cardiol 1983, 51:1679-1681.
73. Maisch B., Seferovic P.M., Ristic A.D., et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; the task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology. Eur Heart J 2004, 25:587-610.
74. Bertog S.C., Thambidorai S.K., Parakh K., et al. Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol 2004, 43:1445-1452.
75. Karram T., Rinkevitch D., Markiewicz W. Poor outcome in radiation-induced constrictive pericarditis. Int J Radiat Oncol Biol Phys 1993, 25:329-331.
76. Seifert F.C., Miller D.C., Oesterle S.N., et al. Surgical treatment of constrictive pericarditis: Analysis of outcome and diagnostic error. Circulation 1985, 72:II264-II273.
77. Talreja D.R., Edwards W.D., Danielson G.K., et al. Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation 2003, 108:1852-1857.
78. Stewart J.R., Fajardo L.F. Radiation-induced heart disease: an update. Prog Cardiovasc Dis 1984, 27:173-194.
79. Veinot J.P., Edwards W.D. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol 1996, 27:766-773.
80. Heidenreich P.A., Hancock S.L., Vagelos R.H., Lee B.K., Schnittger I. Diastolic dysfunction after mediastinal irradiation. Am Heart J 2005, 150:977-982.
81. Lee P.J., Mallik R. Cardiovascular effects of radiation therapy: practical approach to radiation therapy-induced heart disease. Cardiol Rev 2005, 13:80-86.
82. Adams M.J., Lipshultz S.E., Schwartz C., et al. Radiation-associated cardiovascular disease: manifestations and management. Semin Radiat Oncol 2003, 13:346-356.
83. Green D.M., Gingell R.L., Pearce J., Panahon A.M., Ghoorah J. The effect of mediastinal irradiation on cardiac function of patients treated during childhood and adolescence for Hodgkin's disease. J Clin Oncol 1987, 5:239-245.
84. Slama M.S., Le Guludec D., Sebag C., et al. Complete atrioventricular block following mediastinal irradiation: a report of six cases. Pacing Clin Electrophysiol 1991, 14:1112-1118.
85. Martin J.D., Buckley A.R., Graeb D., et al. Carotid artery stenosis in asymptomatic patients who have received unilateral head-and-neck irradiation. Int J Radiat Oncol Biol Phys 2005, 63:1197-1205.
86. Dorresteijn L.D., Kappelle A.C., Scholz N.M., et al. Increased carotid wall thickening after radiotherapy on the neck. Eur J Cancer 2005, 41:1026-1030.
87. King L.J., Hasnain S.N., Webb J.A., et al. Asymptomatic carotid arterial disease in young patients following neck radiation therapy for Hodgkin lymphoma. Radiology 1999, 213:167-172.
88. De Bruin M.L., Dorresteijn L.D., van't Veer M.B., et al. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst 2009, 101:928-937.